Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)
CNY 57.39
(-0.92%)
CNY 57.39
(-0.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -844.61 Million CNY | -60.84% |
| 2022 | -525.11 Million CNY | 43.29% |
| 2021 | -925.97 Million CNY | 19.0% |
| 2020 | -1.14 Billion CNY | -393.52% |
| 2019 | -231.63 Million CNY | -215.76% |
| 2018 | -73.35 Million CNY | -33.19% |
| 2017 | -55.07 Million CNY | -484.04% |
| 2016 | -9.42 Million CNY | -12.38% |
| 2015 | -8.39 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -593.72 Million CNY | 25.56% |
| 2024 Q1 | -797.63 Million CNY | 5.56% |
| 2024 Q3 | -545.9 Million CNY | 8.05% |
| 2023 Q4 | -844.61 Million CNY | -38.83% |
| 2023 FY | -844.61 Million CNY | -60.84% |
| 2023 Q2 | -491.68 Million CNY | 0.77% |
| 2023 Q1 | -495.48 Million CNY | 5.64% |
| 2023 Q3 | -608.37 Million CNY | -23.73% |
| 2022 Q2 | -502.73 Million CNY | 21.15% |
| 2022 FY | -525.11 Million CNY | 43.29% |
| 2022 Q4 | -525.11 Million CNY | -17.28% |
| 2022 Q3 | -447.75 Million CNY | 10.94% |
| 2022 Q1 | -637.61 Million CNY | 31.14% |
| 2021 Q4 | -925.97 Million CNY | -14.31% |
| 2021 FY | -925.97 Million CNY | 19.0% |
| 2021 Q3 | -810.05 Million CNY | 10.93% |
| 2021 Q1 | -973.17 Million CNY | 15.04% |
| 2021 Q2 | -909.43 Million CNY | 6.55% |
| 2020 Q2 | -1.3 Billion CNY | -508.48% |
| 2020 Q1 | -213.87 Million CNY | 7.66% |
| 2020 FY | -1.14 Billion CNY | -393.52% |
| 2020 Q3 | -1.08 Billion CNY | 16.62% |
| 2020 Q4 | -1.14 Billion CNY | -5.56% |
| 2019 Q1 | 92.35 Million CNY | 225.9% |
| 2019 Q4 | -231.63 Million CNY | 0.0% |
| 2019 FY | -231.63 Million CNY | -215.76% |
| 2018 Q3 | -27.03 Million CNY | 0.0% |
| 2018 Q4 | -73.35 Million CNY | -171.29% |
| 2018 FY | -73.35 Million CNY | -33.19% |
| 2017 FY | -55.07 Million CNY | -484.04% |
| 2016 FY | -9.42 Million CNY | -12.38% |
| 2015 FY | -8.39 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Beijing Scitop Bio-tech Co., Ltd. | -179.94 Million CNY | -369.377% |
| Lifecome Biochemistry Co.,Ltd. | 878.34 Million CNY | 196.16% |
| NanHua Bio-medicine Co., Ltd | -449.53 Million CNY | -87.886% |
| Shandong Sito Bio-technology Co., Ltd. | 553.09 Million CNY | 252.707% |
| Porton Pharma Solutions Ltd. | 242.94 Million CNY | 447.656% |
| Zhejiang Wecome Pharmaceutical Company Limited | 105.08 Million CNY | 903.771% |
| Guangdong VTR Bio-Tech Co., Ltd. | -540.91 Million CNY | -56.145% |